These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Atypical stroma cells in prostatic cancer: tumoral or reactive change?]. Kiss F; Arató G; Schmidt L Morphol Igazsagugyi Orv Sz; 1986 Oct; 26(4):233-7. PubMed ID: 2431302 [No Abstract] [Full Text] [Related]
8. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer]. Ishikawa A Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320 [TBL] [Abstract][Full Text] [Related]
9. Early detection and treatment of prostatic carcinoma. Sakkas JL Int Surg; 1970 Jul; 54(1):65-7. PubMed ID: 4099124 [No Abstract] [Full Text] [Related]
10. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis. Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of occult prostatic cancer]. Proca E; Zamfir V; Popovici D Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1986; 35(3):161-9. PubMed ID: 2428081 [No Abstract] [Full Text] [Related]
12. DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomy. Romics I; Bocsi J; Bach D; Beutler W; Frang D; Kopper L Anticancer Res; 1995; 15(3):1131-4. PubMed ID: 7645937 [TBL] [Abstract][Full Text] [Related]
13. [Prostatic carcinoma. Incidence and significance of stage I - preclinical carcinoma]. Schmassmann A; Mihatsch MJ Urologe A; 1983 Sep; 22 Suppl():388-92. PubMed ID: 6685389 [TBL] [Abstract][Full Text] [Related]
14. [Prostatic cancer before the age of 50. Diagnostic and therapeutic considerations]. Aubert J Rev Med Suisse Romande; 1992 Sep; 112(9):769-73. PubMed ID: 1411036 [No Abstract] [Full Text] [Related]
15. [Prevalence of the individual stages of prostatic cancer at the time of diagnosis]. Mogensen P; Frimodt-Møller C Ugeskr Laeger; 1981 Jun; 143(26):1644-6. PubMed ID: 7292724 [No Abstract] [Full Text] [Related]
16. [Errors and difficulties in clinical diagnosis of prostatic cancer. (From data of pathologo-anatomical studies)]. Samsonov VA Urol Nefrol (Mosk); 1988; (6):45-8. PubMed ID: 3232266 [No Abstract] [Full Text] [Related]
17. Immunohistochemistry in the diagnosis of difficult cases of prostatic cancer. Caillaud JM; Mathieu MC; Carlu C Prog Clin Biol Res; 1987; 243A():477-83. PubMed ID: 2443919 [No Abstract] [Full Text] [Related]
18. [Natural follow-up of prostate cancer and consequences for early detection]. Schmid HP Schweiz Rundsch Med Prax; 1993 Nov; 82(44):1239-43. PubMed ID: 7505945 [TBL] [Abstract][Full Text] [Related]
19. [Value of prognostic factors in prostate cancer]. Schubert J; Kowalik S Z Arztl Fortbild (Jena); 1993 Jul; 87(7):593-7. PubMed ID: 8362544 [No Abstract] [Full Text] [Related]
20. [Study on the diagnosis of prostatic cancer by detecting methylated GSTP1 promotor region from the urinary samples]. Kato T Hokkaido Igaku Zasshi; 2005 Mar; 80(2):251-61. PubMed ID: 15868711 [No Abstract] [Full Text] [Related] [Next] [New Search]